Check-Cap Ltd. Interest Expense 2011-2026 | CHEK

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Check-Cap Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	13 K	12 K	13 K	12 K	8 K	7 K	7 K	7 K	47 K	6 K	5 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
47 K	5 K	12.5 K

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	106 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
Burning Rock Biotech Limited BNR	1.54 M	$ 29.8	-3.87 %	$ 321 M	China
Accelerate Diagnostics AXDX	235 K	-	-61.36 %	$ 2.46 M	USA
Co-Diagnostics CODX	106 K	-	-	$ 79.8 M	USA
BioNano Genomics BNGO	-10.1 M	$ 1.13	-3.54 %	$ 1.44 M	USA
Castle Biosciences CSTL	1 K	-	-	$ 914 M	USA
Danaher Corporation DHR	-56 M	$ 219.93	0.09 %	$ 161 B	USA
Celcuity CELC	2.11 M	$ 104.25	0.08 %	$ 4.11 B	USA
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
DexCom DXCM	20.3 M	-	-	$ 26.3 B	USA
Quest Diagnostics Incorporated DGX	30 M	$ 209.75	2.09 %	$ 23.3 B	USA
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Genetic Technologies Limited GENE	15.2 K	-	-	$ 7.1 B	Australia
CareDx, Inc CDNA	1.34 M	$ 19.51	-5.18 %	$ 1.05 B	USA
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
DarioHealth Corp. DRIO	-31 K	$ 11.07	1.37 %	$ 314 M	Israel
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
Exact Sciences Corporation EXAS	18.6 M	$ 103.42	-	$ 19.2 B	USA
Interpace Biosciences IDXG	-394 K	$ 1.82	-	$ 7.98 M	USA
Lantheus Holdings LNTH	37.2 M	$ 67.04	-	$ 4.64 B	USA
Fulgent Genetics FLGT	561 K	$ 23.02	-	$ 696 M	USA
Mettler-Toledo International MTD	68.5 M	-	-0.62 %	$ 28.7 B	Schweiz
Guardant Health GH	-42.6 M	$ 106.6	1.65 %	$ 13.1 B	USA
NeoGenomics NEO	-379 K	$ 11.47	-	$ 1.45 B	USA
QIAGEN N.V. QGEN	-739 K	-	-	$ 10.6 B	Niderland
Natera NTRA	9.32 M	-	-0.5 %	$ 20.7 B	USA
OPKO Health OPK	207 M	$ 1.25	2.05 %	$ 868 M	USA
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Charles River Laboratories International CRL	-16.5 M	-	-9.16 %	$ 8.49 B	USA
Koninklijke Philips N.V. PHG	288 M	$ 32.03	-2.72 %	$ 20 B	Niderland
IDEXX Laboratories IDXX	29.8 M	-	-	$ 53.5 B	USA
Illumina ILMN	-292 M	$ 117.01	-1.95 %	$ 18.6 B	USA
IQVIA Holdings IQV	670 M	$ 176.27	-	$ 32 B	USA
Biodesix BDSX	8.26 M	-	-	$ 1.33 B	USA
Laboratory Corporation of America Holdings LH	208 M	$ 289.4	1.75 %	$ 24.3 B	USA
ENDRA Life Sciences NDRA	-691 K	$ 3.56	-4.56 %	$ 1.91 M	USA
ICON Public Limited Company ICLR	337 M	-	-	$ 11 B	Irlanda
Biomerica BMRA	367	$ 2.23	-	$ 5.12 M	USA
Bioventus BVS	1.29 M	$ 8.04	-	$ 504 M	USA